<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30141822</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>19</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1474-9092</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>17</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>10</Day>                    </PubDate>                </JournalIssue>                <Title>Photochemical &amp; photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology</Title>                <ISOAbbreviation>Photochem. Photobiol. Sci.</ISOAbbreviation>            </Journal>            <ArticleTitle>Bottom-up synthesis of MoS<sub>2</sub> nanospheres for photothermal treatment of tumors.</ArticleTitle>            <Pagination>                <MedlinePgn>1337-1345</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1039/c8pp00198g</ELocationID>            <Abstract>                <AbstractText>Photothermal therapy (PTT) is providing new opportunities for killing cancer cells. In this work, we introduce a new nanomedicine based on spherical MoS2 nanoparticles for PTT treatment of tumors, prepared using &quot;green&quot; bottom-up technology. To increase water solubility and avoid rapid clearance by the reticuloendothelial system, polyethylene glycol (PEG) was used to coat them. These MoS2-PEG nanospheres with an appropriate size (âˆ¼100 nm) exhibit high photothermal conversion efficiency (26.7%). In vitro cellular studies revealed that the MoS2-PEG nanospheres showed negligible cytotoxicity. Additionally, through combining the MoS2-PEG nanosphere samples with NIR irradiation at 808 nm, excellent in vitro tumor cell killing efficacy was achieved. In the 4T1 tumor model, the MoS2-PEG nanospheres exhibited good antitumor efficiency in vivo, displaying complete tumor inhibition over 16 days after treatment. Therefore, MoS2-PEG nanospheres played an important role in tumor destruction, and this concept for developing spherical MoS2-based nanomedicines can serve as a platform technology for the next generation of in vivo PTT agents.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Gao</LastName>                    <ForeName>Shun</ForeName>                    <Initials>S</Initials>                    <Suffix/>                    <AffiliationInfo>                        <Affiliation>Tianjin Institute of Metrological Supervision and Testing, 300192, Tianjin, PR China. tonghualang@126.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhou</LastName>                    <ForeName>Hailiang</ForeName>                    <Initials>H</Initials>                    <Suffix/>                </Author>                <Author ValidYN="Y">                    <LastName>Cui</LastName>                    <ForeName>Sumei</ForeName>                    <Initials>S</Initials>                    <Suffix/>                </Author>                <Author ValidYN="Y">                    <LastName>Shen</LastName>                    <ForeName>Hai</ForeName>                    <Initials>H</Initials>                    <Suffix/>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Photochem Photobiol Sci</MedlineTA>            <NlmUniqueID>101124451</NlmUniqueID>            <ISSNLinking>1474-905X</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004220">Disulfides</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>30IQX730WE</RegistryNumber>                <NameOfSubstance UI="D011092">Polyethylene Glycols</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>81AH48963U</RegistryNumber>                <NameOfSubstance UI="D008982">Molybdenum</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>ZC8B4P503V</RegistryNumber>                <NameOfSubstance UI="C082964">molybdenum disulfide</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004220" MajorTopicYN="N">Disulfides</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006979" MajorTopicYN="N">Hyperthermia, Induced</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008982" MajorTopicYN="N">Molybdenum</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D050997" MajorTopicYN="N">Nanomedicine</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D054118" MajorTopicYN="N">Nanospheres</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>                <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D036103" MajorTopicYN="N">Nanotechnology</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010789" MajorTopicYN="N">Phototherapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011092" MajorTopicYN="N">Polyethylene Glycols</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30141822</ArticleId>            <ArticleId IdType="doi">10.1039/c8pp00198g</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>